Champions Oncology, Inc. (CSBR)
NASDAQ: CSBR · Real-Time Price · USD
6.87
+0.33 (5.13%)
Aug 13, 2025, 4:00 PM - Market closed
Champions Oncology Employees
Champions Oncology had 213 employees as of April 30, 2025. The number of employees increased by 3 or 1.43% compared to the previous year.
Employees
213
Change (1Y)
3
Growth (1Y)
1.43%
Revenue / Employee
$267,343
Profits / Employee
$22,070
Market Cap
94.58M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
CSBR News
- 20 days ago - Champions Oncology (CSBR) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 21 days ago - Champions Oncology Reports Record Annual Revenue of $57 Million - Accesswire
- 24 days ago - Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Wednesday, July 23, 2025 - Accesswire
- 27 days ago - Champions Oncology Announces Appointment of New CEO - Accesswire
- 5 weeks ago - Champions Oncology Launches Radiopharmaceutical Services Platform, Expands Isotope License, and Screens More Than 30 PDX Models - Accesswire
- 2 months ago - Champions Oncology: Biological IP Is The Real Asset - Not Preclinical Services - Seeking Alpha
- 3 months ago - Champions Oncology Obtains Radioactive Materials License to Advance Comprehensive Radiotherapeutic Studies In-House - Accesswire
- 4 months ago - Champions Oncology's Data Platform Gains Momentum through a Strategic Collaboration with Turbine - Accesswire